Planatome, a medical device company, has successfully closed a $5 million Series A equity investment round and secured an additional $1 million convertible venture debt commitment[2ea9d8bd]. The funds will be utilized to hire commercial talent, expand manufacturing capacity, and create new business lines[2ea9d8bd]. Planatome specializes in applying atomic-level polishing from the semiconductor industry to develop advanced surgical blades[2ea9d8bd]. Their patented surface modification technology enhances the smoothness of surgical blades, resulting in low-trauma, high-precision tools[2ea9d8bd]. Surgeons who use Planatome blades experience less soft tissue damage, cleaner margins, and fewer complications, while patients benefit from reduced inflammation, pain, faster healing, and less scarring[2ea9d8bd]. The blades have received approval for use in the United States and South Korea and have recently gained approval from several hospitals and surgical centers[2ea9d8bd].